The coming together of INC Research and inVentiv Health as one global company, called Syneos Health, has created the industry’s only true end-to-end biopharma solutions organization.
We combine world-renowned clinical research and commercialization capabilities with today’s most advanced science, business, and data technologies to make real advances possible. We help you improve brand performance, reduce risk, and expedite delivery of healthcare innovation to patients.
Serving customers of all sizes, our CCO (Contract Commercial Organization) capabilities are the most robust in the industry, delivering flexible, targeted, multichannel programs designed to produce a higher likelihood of launch success. At the same time, our commercial and market insights along with proprietary data access can improve clinical trial design and accelerate patient recruitment. It’s a powerful platform purpose-built for the modern biopharmaceutical world.
Syneos Health™
3201 Beechleaf Court, Suite 600
Raleigh, NC 27604-1547
+1 866 462 7373
syneoshealth.com
Year Founded: 2017 through the merger of INC Research and inVentiv Health
Number of Employees: 21,000+
New Business Contact:
Dominic Marasco
EVP, Global Business Development, Commercial
+1 610 659 6938
dominic.marasco@syneoshealth.com
Michelle Keefe, President, Commercial Solutions
“Our flexible, targeted programs complement traditional outsourced reps with MSLs, reimbursement specialists, and sophisticated market access and multichannel capabilities. Coupled with our ability to tap insights generated earlier in the trial process, we provide a powerful platform designed to produce a higher likelihood of launch success.”
